Sinopharm YiXin Pharmaceutical

Sinopharm Yixin Pharmaceutical is a specialized pharmaceutical company based in Dalian, China, and a key subsidiary of the state-owned Sinopharm Group. The company is primarily dedicated to the research, development, and manufacturing of anti-tumor medications, positioning itself as a major provider of oncology treatments in the Chinese market. Its product portfolio consists of essential chemotherapy agents, including oxaliplatin, irinotecan, and docetaxel, which are used to treat various cancers such as colorectal and breast cancer. Sinopharm Yixin operates advanced manufacturing facilities that comply with stringent GMP standards for both injectable and oral dosage forms. By integrating with Sinopharm's extensive distribution network, the company ensures that its life-saving oncology products reach healthcare providers and patients nationwide.